Florencio Zaragoza Dörwald

Title: Florencio Zaragoza Dörwald: Innovator in Protein Conjugates

Introduction

Florencio Zaragoza Dörwald is a prominent inventor based in Smørum, Denmark. He has made significant contributions to the field of biochemistry, particularly in the development of protein conjugates and methods for their preparation. With a total of 7 patents, Dörwald's work has had a substantial impact on therapeutic applications.

Latest Patents

Dörwald's latest patents include innovative approaches to creating hydrolytically stable protein conjugates. One notable patent focuses on the reductive amination of peptide-derived aldehydes with anilines or heteroarylamines that contain a property-modifying group. This method provides new protein conjugates suitable for therapeutic use. Another significant invention involves polypeptide protracting tags, which are designed to increase the plasma half-life of molecules such as human growth hormone by covalently linking them to a heterocyclic carboxylic acid bioisostere.

Career Highlights

Throughout his career, Dörwald has worked with leading companies in the pharmaceutical industry, including Novo Nordisk A/S and Novo Nordisk Healthcare AG. His expertise in biochemistry and innovative thinking has positioned him as a key figure in the development of new therapeutic strategies.

Collaborations

Dörwald has collaborated with notable professionals in his field, including Bernd Peschke and Christine Bruun Schiødt. These collaborations have further enhanced his research and development efforts, leading to groundbreaking advancements in protein conjugate technology.

Conclusion

Florencio Zaragoza Dörwald's contributions to the field of biochemistry and his innovative patents have paved the way for new therapeutic applications. His work continues to influence the development of protein conjugates, showcasing the importance of innovation in the medical field.